Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.2.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at the beginning at Jun. 30, 2021 $ 20,010 $ 1 $ 151,583 $ (130,119) $ (1,455)
Balance at the beginning (In shares) at Jun. 30, 2021   8,171,690      
Share-based compensation 271   271    
Foreign currency translation gain 239       239
Net loss (5,045)     (5,045)  
Balance at end at Sep. 30, 2021 15,475 $ 1 151,854 (135,164) (1,216)
Balance at end (In shares) at Sep. 30, 2021   8,171,690      
Balance at the beginning at Jun. 30, 2022 2,882 $ 1 152,453 (148,327) (1,245)
Balance at the beginning (In shares) at Jun. 30, 2022   8,171,690      
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs of $1,869 16,015 $ 2 16,013    
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs of $1,869, Shares   17,637,843      
Share-based compensation 302   302    
Foreign currency translation gain 507       507
Net loss (5,093)     (5,093)  
Balance at end at Sep. 30, 2022 $ 14,613 $ 3 $ 168,768 $ (153,420) $ (738)
Balance at end (In shares) at Sep. 30, 2022   25,809,533